Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2147284
Reference Type
Journal Article
Subtype
Abstract
Title
The in-vitro metabolism of 2-acetylaminofluorene in mouse liver
Author(s)
Gough, BJ; Baetcke, KP; Shellenberger, TE
Year
1974
Is Peer Reviewed?
1
Journal
Toxicology and Applied Pharmacology
ISSN:
0041-008X
EISSN:
1096-0333
Report Number
HEEP/75/07650
Volume
29
Issue
1
Page Numbers
107
Language
English
Relationship(s)
is part of a larger document
3378179
Abstracts of papers for the Thirteenth Annual Meeting of the Society of Toxicology, Washington, D.C. March 10–14, 1974
Abstract
A modified in vitro system for the metabolism of 2-acetylaminofluorine (2-AAF) was developed. The system depends upon utilization of a NADPH-generating system, low amounts of microsomal protein (0.5-1.0 mg) and substrate (660 ng), and utilization of HEPES buffer. With these modifications, the in vitro metabolism of 2-AAF was found to be linear with time and after 30 min incubation, formation of N-hydroxy-2-acetylaminofluorine (N-OH-2-AAF) represented 30 % or greater of the 2-AAF added originally. Using this modified in vitro system in a 14-day preliminary study, mice fed a purina diet were found to metabolize 30% more of the added 2-AAF to N-OH-2-AAF than did mice receiving a synthetic diet. In another study, 2-AAF was added to diets of mice (100 ppm in Purina or synthetic) for periods of up to 18 weeks. Determinations of in vitro 2-AAF metabolism were made at periodic intervals and it was found that feeding of 2-AAF in the diet exerted little, if any influence on the conversion of 2-AAF to N-OH-2-AAF or to the 5- or 7-OH metabolites when compared to control animals.
Conference Name
Thirteenth Annual Meeting of the Society of Toxicology
Conference Location
Washington, D.C.
Conference Dates
March 10–14, 1974
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity